Differentiation and Expansion of Tumor-Infiltrating T Cell Clonotypes Occurs in the Spleen Following Immune Checkpoint Blockade
D. M. Morgan, B. L. Horton, M. Zagorulya, J. C. Love, S. Spranger
This study identifies spleen-resident intermediate-exhausted T cells as key to ICB efficacy, showing their expansion and differentiation into tumor-infiltrating clonotypes.
bioRxiv · Sep 4, 2023 · PreprintImmunology